Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity
Public ClinicalTrials.gov record NCT03013543. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study was to determine the effect of setmelanotide (RM-493) on weight, hunger assessments, and other factors in participants with rare genetic disorders of obesity.
Study identification
- NCT ID
- NCT03013543
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 213 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 6 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 10, 2017 (Actual)
- Primary completion
- Mar 1, 2022 (Actual)
- Completion
- Mar 1, 2022 (Actual)
- Last update posted
- Aug 18, 2023
2017 – 2022
United States locations
- U.S. sites
- 43
- U.S. states
- 24
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Synexus Clinical Research US, Inc. - Simon Williamson Clinic, PC | Birmingham | Alabama | 35211 | — |
| Synexus Clinical Research US, Inc. - Phoenix Southeast | Chandler | Arizona | 85224 | — |
| Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC | Mesa | Arizona | 85206 | — |
| Honor Health Research Institute | Scottsdale | Arizona | 85258 | — |
| Axis Clinical Trials-Downtown | Los Angeles | California | 90017 | — |
| Axis Clinical Trials Headquarters | Los Angeles | California | 90036 | — |
| San Diego Wake Research | San Diego | California | 92108 | — |
| Anschutz Health and Wellness Center University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | — |
| Division of Endocrinology and Diabetes Children's National Hospital | Washington D.C. | District of Columbia | 20010 | — |
| University of Florida College of Medicine | Gainesville | Florida | 32610 | — |
| AXIS South Florida Clinical Trials | Hialeah | Florida | 33016 | — |
| Florida Hospital | Orlando | Florida | 32804 | — |
| Synexus Clinical Research US, Inc. - St. Petersburg | Pinellas Park | Florida | 33781 | — |
| Synexus Clinical Research US, Inc. - Chicago | Chicago | Illinois | 60602 | — |
| Maine Medical Partners | Portland | Maine | 04102 | — |
| NIH Hatfield Clinical Research Center | Bethesda | Maryland | 20892 | — |
| Baystate Medical Center | Springfield | Massachusetts | 01107 | — |
| University of Michigan Medicine | Ann Arbor | Michigan | 48105 | — |
| Precision Medicine for Obesity Research: Gastroenterology & Hepatology Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Washington University St. Louis | St Louis | Missouri | 63110 | — |
| Impact Clinical Trials | Las Vegas | Nevada | 89106 | — |
| AXIS New York Clinical Trials | Brooklyn | New York | 11201 | — |
| University at Buffalo | Buffalo | New York | 14203 | — |
| AXIS Clinical Trials | New York | New York | 10022 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10025 | — |
| Columbia University | New York | New York | 10032 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| Wake Research Inc. | Raleigh | North Carolina | 27612 | — |
| Synexus Clinical Research US, Inc. - Akron | Akron | Ohio | 44311 | — |
| Synexus Clinical Research US, Inc. - Cincinnati | Cincinnati | Ohio | 45236 | — |
| Synexus Clinical Research US, Inc. - Columbus | Columbus | Ohio | 43016 | — |
| Obesity Institute, Geisinger Clinic | Danville | Pennsylvania | 17822 | — |
| Childrens Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| Synexus Clinical Research US, Inc. - Primary Care Associates, PC | Anderson | South Carolina | 29621 | — |
| Wake Research TN | Chattanooga | Tennessee | 37421 | — |
| Le Bonheur Children's Hospital | Memphis | Tennessee | 38103 | — |
| Vanderbilt University School of Medicine | Nashville | Tennessee | 37212-3157 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Synexus Clinical Research US, Inc. - Plano | Plano | Texas | 75093 | — |
| Synexus Clinical Research US, Inc. - San Antonio | San Antonio | Texas | 78229 | — |
| University of Utah | Salt Lake City | Utah | 84132 | — |
| Seattle Children's Research Institute | Seattle | Washington | 98101 | — |
| Marshfield Clinic Research Institute | Marshfield | Wisconsin | 54449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03013543, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2023 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03013543 live on ClinicalTrials.gov.